REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam — Stella

Recruiting

Back to Hemorrhagic Shock trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

University of Cincinnati, Cincinnati, Ohio

Key details

Sponsor

Arsenal Medical, Inc.

Enrollment target

~40 participants

Started

August 2025

Primary completion

October 2026

Age range

15 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov